"The technology and devices for needle-free delivery of drugs/vaccines has been available in the market since several decades. Although their market penetration has been low, the recent years have seen an increase in adoption, driven by the need for pain free delivery. Currently, the market for needle-free delivery devices is dominated by small medical device companies and academic researchers. These small scale companies are developing innovative needle-free delivery technologies, with the pharmaceutical companies entering into partnership with the device developers for using the technology for delivery of the company's drug. Teva Pharmaceuticals is using the Tjet injector system developed by Antares Pharma for delivery of TEV-TROPIN. We expect the pharmaceutical companies to begin developing drugs specifically for use with the needle-free systems, in the near future. According to our latest pharma report - Needle-Free Delivery: Technology and Market 2012-2022 - the global needle-free delivery devices market will be worth $2.1bn by 2016.
Needle-Free Delivery: Technology and Market 2012-2022 report forecasts the size and value of leading national markets: the US, EU5, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period.
The needle-free delivery technology is advantageous for the drug and device developers as well as the end-users. The various factors backing the adoption of the needle-free devices include, but are not limited to, the ease of use, pain-free delivery, differentiation for product line extensions and life cycle management. However, the market is also faced with challenges of high cost, manufacturing inefficiencies, and reimbursement issues owing to the low cost of traditional delivery using hypodermic needles."
quelle:bizjournals |
Thread abonnieren
Dies gilt insbesondere für einige besonderes aktive Hobbyanalysten im Umfeld dieses Invests. Irgendwie fehlt es an der Fähigkeit sich von der Vergangenheit zu lösen und ein wenig Phantasie für die Zukunft mitzubringen. Mit solchen Veranlagungen wird man immer nur den Entwicklungen hinterherlaufen, aber nie mit ihnen einhergehen bzw. ihnen voraus sein. Wenn man einen Disclaimer schon als Gesetzetext ausgibt, dann bleibt für weitere Diskussionen wenig Gemeinsamkeit und Raum. Dabei wären viele Dinge (siehe a.m.l.e) welche man diskutieren könnte.